The effect of preimplantation genetic testing for aneuploidy (PGT-A) on in vitro fertilization (IVF) outcomes with donor oocytes and utilization of elective single embryo transfer (ESET)
Aneuploidy is a known detrimental factor limiting embryo implantation in patients undergoing IVF. As such, PGT-A has been shown to be a successful strategy to improve rates of embryo implantation and reduce the risk of miscarriage. ESET has also been shown to reduce the morbidity and mortality that is associated with multiple gestations. ESET with PGT-A has been well-studied among patients undergoing IVF with autologous oocytes, but few studies have examined the use of PGT-A with donor oocytes (DO).
Source: fertstert.org
The effect of preimplantation genetic testing for aneuploidy (PGT-A) on in vitro fertilization (IVF) outcomes with donor oocytes and utilization of elective single embryo transfer (ESET)
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment